Copy Link Print Information

Cabiralizumab

(Synonyms: FPA 008; Anti-Human CSF1R Recombinant Antibody)
Customer Review

Based on 1 Customer Validation

Cabiralizumab (FPA 008) is an anti-CSF1R monoclonal antibody (MAb). Cabiralizumab enhances T cell infiltration and antitumor T cell immune responses. Cabiralizumab inhibits the activation of osteoclasts and blocks bone destruction, and can be used in the research of rheumatoid arthritis (RA). Cabiralizumab can combine with Nivolumab (HY-P9903) for lung cancer research.

For research use only. We do not sell to patients.

  • Purity: 99.73%
  • CAS No.: 1613144-80-1
  • Molecular Weight:146.02 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Cabiralizumab
  • Experimental Validation Results for Cabiralizumab
  • Experimental Validation Results for Cabiralizumab
  • Cabiralizumab Chemical Structure
    Cabiralizumab Chemical Structure
CAS No.: 1613144-80-1
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Cabiralizumab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG4 kappa

  • 1/16

    Immobilized Human M-CSFR/CSF1R Protein can bind Cabiralizumab. The EC50 for this effect is 2.465 ng/mL.

  • 1/16

    Flow cytometric analysis of 1.5X106 THP-1 cells labeling Cabiralizumab (HY-P99259, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG4 kappa (HY-P99003, blue) was used as the isotype control.

  • Cabiralizumab Chemical Structure
    1/16
  • Cabiralizumab
  • Immobilized Human M-CSFR/CSF1R Protein can bind Cabiralizumab. The EC50 for this effect is 2.465 ng/mL.
  • Flow cytometric analysis of 1.5X106 THP-1 cells labeling Cabiralizumab (HY-P99259, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG4 kappa (HY-P99003, blue) was used as the isotype control.